Vanderbilt University School of Medicine, National Foundation for Infectious DiseasesDisclosures
Dr. Schaffner is or has been an occasional consultant for Pfizer, Novartis, GlaxoSmithKline and Dynavax. He is a member of the Data Safety Monitoring Boards for experimental vaccine trails at Merck.
|Program Name||Last Air Date||Hosts/Guests|
|How Improved Hepatitis B Vaccination Coverage Can Protect At-Risk Adults||01/23/2019|
|The Importance of Immunizations in Long Term Care||06/03/2016|
|Boosting Immunization Rates for Adult Shingles||05/18/2008|
|Vaccinating for Adult Shingles: New Initiatives||06/22/2008|
|The Adult Shingles Vaccine: Challenges of Delivery||04/27/2008|
|The History of Research Into Vaccines for Shingles||04/13/2008|
|Have your adult patients been vaccinated?||12/16/2007|
|Diabetes and Vaccination||11/18/2007|
You need to be logged in to save this episode to a playlist.
You must be logged in to display playlists.